Aktie • Pharma

Zugehörige Wertpapiere Astellas Pharma

WKN
ISIN
Land
Japan 🇯🇵
Ticker
•
WKN
Land
Japan 🇯🇵
ISIN
Ticker
•
•
13,83 USD
-0,99 USD-6,68 %
Tagesvolumen
804 Stk.
Tagesspanne
13,55  –  13,83 USD
52W-Spanne
8,41  –  17,39 USD
Marktkapitalisierung
23,42 Mrd. EUR
Dividendenrendite
3,45 %
KGV
13,50
Gewinn pro Aktie
0,98 EUR
theScreener Rating
Nachhaltigkeits-Score
–
Merkmal Als Sparplan verfügbar

Zugehörige Fonds zur Astellas Pharma Aktie

NameKVGAnteil am Fonds
Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare - I USD ACC
WKN A2DPA1 · ISIN LU1587984680
Waystone4,14 %
Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare - I2 USD ACC
WKN A2DPA2 · ISIN LU1587984763
Waystone4,14 %
Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare - B USD ACC
WKN A2DPA3 · ISIN LU1587984847
Waystone4,14 %
Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare - I CHF ACC
WKN A2DPA4 · ISIN LU1587984920
Waystone4,14 %
Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare - I2 CHF ACC
WKN A2DPA5 · ISIN LU1587985067
Waystone4,14 %
Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare - B CHF ACC
WKN A2DPA6 · ISIN LU1587985141
Waystone4,14 %
Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare - I EUR ACC
WKN A2DPA7 · ISIN LU1587985224
Waystone4,14 %
Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare - I2 EUR ACC
WKN A2DPA8 · ISIN LU1587985497
Waystone4,14 %
Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare - B EUR ACC
WKN A2DPA9 · ISIN LU1587985570
Waystone4,14 %
Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare - AI2 USD DIS
WKN A2N92Q · ISIN LU1916264515
Waystone4,14 %
JP Morgan Thematics - Genetic Therapies A USD Acc.
WKN A2PR4K · ISIN LU2050612402
JPMorgan3,29 %
JPMorgan Funds - Thematics - Genetic Therapies - C2 USD ACC
WKN A2PR4L · ISIN LU2050612154
JPMorgan3,29 %
JP Morgan Thematics - Genetic Therapies A EUR Acc. Hedged
WKN A2PR3U · ISIN LU2053353079
JPMorgan3,29 %
JPMorgan Funds - Thematics - Genetic Therapies - I2 USD ACC
WKN A2PY9W · ISIN LU2112815027
JPMorgan3,29 %
JPMorgan Funds - Thematics - Genetic Therapies - I2 EUR ACC H
WKN A2P00D · ISIN LU2127216625
JPMorgan3,29 %
JP Morgan Thematics - Genetic Therapies C USD Acc.
WKN A2PXUN · ISIN LU2098775203
JPMorgan3,29 %
JPMorgan Funds - Thematics - Genetic Therapies - C2 EUR ACC H
WKN A2PR3V · ISIN LU2053353152
JPMorgan3,29 %
JP Morgan Thematics - Genetic Therapies A EUR Dis. Hedged
WKN A2PR3W · ISIN LU2053353236
JPMorgan3,29 %
JPMorgan Funds - Thematics - Genetic Therapies - C2 EUR DIS H
WKN A2PR3X · ISIN LU2053353319
JPMorgan3,29 %
JP Morgan Thematics - Genetic Therapies A CHF Acc. Hedged
WKN A2PR3Y · ISIN LU2053353400
JPMorgan3,29 %
JPMorgan Funds - Thematics - Genetic Therapies - C2 CHF ACC H
WKN A2PR3Z · ISIN LU2053353582
JPMorgan3,29 %
JP Morgan Thematics - Genetic Therapies A CHF Dis. Hedged
WKN A2PR30 · ISIN LU2053353665
JPMorgan3,29 %
JPMorgan Funds - Thematics - Genetic Therapies - C2 CHF DIS H
WKN A2PR31 · ISIN LU2053353749
JPMorgan3,29 %
JP Morgan Thematics - Genetic Therapies A USD Dis.
WKN A2PR3Q · ISIN LU2053352691
JPMorgan3,29 %
JPMorgan Funds - Thematics - Genetic Therapies - C2 USD DIS
WKN A2PR3R · ISIN LU2053352774
JPMorgan3,29 %